BIOTECHNOLOGY
Biotechnology News Magazine keeps you up to date on what is happening in the biotech field.
It is the essential industry source for biotech, pharma and life science news. The weekly publication covers developments in the industry and its impact on regulation, funding and company strategy.
If you’re interested in biotech, then you will love this free online magazine. Make sure you never miss any biotech news by adding Biotechnology News Magazine to your news reader of choice.
Orbit Discovery and Endevica Bio Enter Multi-target Collaboration to Advance Development of Cachexia Therapeutics
The agreement covers activities ranging from hit ID to development of cell-based assays, with an option for Endevica to further develop the peptide hits resulting from the screening activities.
SK bioscience Introduces New Partnership Model to Establish Regional Vaccine Hubs
Mr. Ahn said, "SK bioscience can transplant vaccine manufacturing facilities, technologies, and products to any countries in need based on the accumulated experiences in R&D and manufacturing we have been building. A bilateral partnership can be established if the country in need is willing to provide funds, human resources, and overall environments with collaboration of global initiatives."
Genmab Announces Net Sales of DARZALEX ® (daratumumab) for 2022
Net sales of DARZALEX ® in 2022 totaled USD 7,977 million. Genmab receives royalties on worldwide net sales from Janssen Biotech, Inc. (Janssen).
CytoReason to License Its IBD Disease Model to Sanofi in Expanded Multiyear, Multimillion Dollar Deal
Under the terms of the expanded agreement, Sanofi will pay CytoReason an undisclosed multimillion dollar amount. Sanofi has previously applied Cytoreason’s cell-centered model to better understand asthma patient subtypes.
Ubiquigent Collaborates with University of Glasgow on Translational Structural Biology to Accelerate Drug Discovery within the (de)Ubiquitylation Field
Dr Mehmet Gundogdu, Principal Scientist, Ubiquigent, commented: “Collaborating with Professor Walden on this project is an exciting opportunity to combine forces in an important therapeutic area. USP30 is a prominent target in the DUB drug discovery space, and this project has great potential to enable the structure-led design and development of novel USP30 modulators.”
Lonza Collaborates with Cristal Therapeutics and McSAF to Expand Bioconjugates Offering
The collaborations will enable the integration of two novel conjugation platforms, McSAF Inside® and CliCr®, into the Lonza Bioconjugation Toolbox